Found 16 matching trials
MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)
PHASE1This is a single-dose clinical study to evaluate the safety, tolerability, ...
Location
ARENSIA Exploratory Medicine-Institutul National de Boli Infectioase Matei Bals ( Site 0004)
A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)
PHASE1The purpose of this study is to learn what happens to MK-8527 in a person's...
Location
Arizona Clinical Trials ( Site 0001)
A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002)
PHASE1This study will evaluate the anti-retroviral activity of MK-8527 in HIV-1 i...
Location
Matei Bals Infectious Diseases Institute ( Site 0001)
A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)
PHASE1Researchers are looking for new medicines to prevent Human Immunodeficiency...
Location
Hassman Research Institute Marlton Site ( Site 0001)
A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)
PHASE1The goal of this study is to learn how MK-8527 moves through the healthy pe...
Location
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0002)
A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020)
PHASE1The goal of this study is to learn about the effect of a study medicine cal...
Location
Pinnacle Research Group ( Site 0002)
Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)
PHASE2This double-blind, placebo-controlled study was designed to assess the safe...
Location
Velocity Clinical Research, North Hollywood ( Site 0054)
A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)
PHASE1The goal of this study is to evaluate the effect of moderate and severe ren...
Location
Research by Design ( Site 0001)
A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)
PHASE1This study is designed to assess the effect of a single dose of MK-8527 on ...
Location
QPS-MRA, LLC-Early Phase (Site 0001)
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
PHASE3Researchers are looking for new medicines to prevent HIV-1 (Human Immunodef...
Location
University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 0006)